Innovators at these companies trust us

The local challenge

Medical technology companies in Munich stand between technological opportunity and regulatory reality: high quality requirements meet fragmented data, strict documentation obligations and the need to integrate solutions quickly into regulated product cycles. Without robust, production-ready AI engineering approaches, many ideas remain unrealized.

Why we have the local expertise

Reruption is headquartered in Stuttgart; we travel regularly to Munich and work on-site with clients — not as external consultants, but as embedded co-preneurs who take responsibility. Our work does not start with slides, but in the client’s P&L: we build, measure and deliver.

Proximity to Bavaria’s economic metropolis is more than geography for us: Munich brings together automotive, insurance and high-tech startups with a growing MedTech cluster. This gives us an understanding of local business models, supplier networks and regulatory expectations that are particularly critical for healthcare devices.

Practically this means: we bring engineers, data architects and compliance experts into workshops at the client, stand up prototypes in days and iterate directly with clinical or QA teams. We understand the role of security and hosting decisions for manufacturers regulated in Germany and the EU.

Our references

Even if we do not have explicit medtech projects listed, our real-world projects demonstrate transferability: for BOSCH we supported the go-to-market of a new display product up to the spin-off decision — experience that helps with the commercialization of devices. At STIHL and Eberspächer we led technical projects that combine manufacturing data, sensor integration and robust product development — core topics also in MedTech hardware.

For document-driven processes and NLP solutions, our projects with Mercedes Benz (recruiting chatbot) and FMG (document search) are relevant: we know how to build secure, compliant communication and search systems that can be adapted for regulatory documentation in healthcare.

About Reruption

Reruption was founded not to disrupt companies, but to rerupt them: we build the systems that replace existing business before the market does. Our co-preneur mentality means we operate like co-founders inside the client company — with entrepreneurial ownership and technical depth.

Our focus rests on four pillars: AI Strategy, AI Engineering, Security & Compliance and Enablement. For medical technology in Munich we combine these pillars into production-ready LLM applications, secure self-hosted infrastructures and practice-oriented copilots that meet regulatory requirements and deliver value in clinical everyday use.

How can we start your AI project in Munich?

We come to Munich, run workshops and deliver a PoC in days that demonstrates technical feasibility, performance and compliance requirements.

What our Clients say

Hans Dohrmann

Hans Dohrmann

CEO at internetstores GmbH 2018-2021

This is the most systematic and transparent go-to-market strategy I have ever seen regarding corporate startups.
Kai Blisch

Kai Blisch

Director Venture Development at STIHL, 2018-2022

Extremely valuable is Reruption's strong focus on users, their needs, and the critical questioning of requirements. ... and last but not least, the collaboration is a great pleasure.
Marco Pfeiffer

Marco Pfeiffer

Head of Business Center Digital & Smart Products at Festool, 2022-

Reruption systematically evaluated a new business model with us: we were particularly impressed by the ability to present even complex issues in a comprehensible way.

AI engineering for medical technology & healthcare devices in Munich: A comprehensive guide

The combination of hardware engineering, medtech compliance and digital medicine opens enormous opportunities in Munich — but only if AI solutions bring production maturity, traceability and security. This deep dive highlights the market, use cases, implementation approaches, technology decisions and organizational prerequisites that manufacturers and device developers in Bavaria must consider.

Market analysis and regional dynamics

Munich is a hub for industry, insurance and tech startups. For medtech companies this means access to specialized suppliers, clinical research partners and investors. At the same time, proximity to large players like Siemens and specialized mid-sized companies creates high expectations for quality and scalability.

Demand for digital assistance systems, telemetry analytics and automated documentation is increasing: hospitals, clinics and medical care centers are looking for solutions that reduce integration costs while meeting regulatory requirements. Munich offers an ecosystem of research institutions, hospitals and accelerator programs for this.

Concrete: high-impact use cases

1) Documentation copilots: Automated, traceable generation and storage of test reports, CE conformity documents and clinical study protocols. Such copilots must be versioned, auditable and data-protection compliant.

2) Clinical workflow assistants: Assistance systems that aggregate OR checklists, device parameters and patient data in real time, make suggestions and orchestrate multi-step workflows — without replacing the responsibility of clinical staff.

3) Regulatory alignment tools: Systems that convert regulatory requirements (MDR, IVDR) into checklists, identify gaps and structure evidence for audits. Automated traceability reports are especially valuable here.

4) Secure AI and infrastructure: Self-hosted models, private chatbots and enterprise knowledge systems that keep data locally or in certified clouds are essential for health data and medical device approval processes.

Implementation approach: from PoC to production

The pragmatic path begins with a clear use-case scope and measurable metrics. Our €9,900 AI PoC offer targets exactly that: delivering a working prototype within days that demonstrates technical feasibility, performance and integration needs. For MedTech it is important to include compliance checks, data classification and security reviews early on.

After the PoC follows an iterative path: harden the model (robustness), establish data pipelines (ETL with secure storage), integrate with backends (APIs, Postgres + pgvector for knowledge systems), and implement a deployment strategy (self-hosted or VPC cloud). In parallel, QA and validation processes must be documented.

Technology stack and architectural decisions

For production systems we recommend modular architectures: API/backend for abstraction (e.g., integrations to OpenAI, Anthropic, Groq), dedicated ETL pipelines for data curation, Postgres + pgvector as a basis for enterprise knowledge systems and self-hosted components when needed (Hetzner, MinIO, Traefik, Coolify).

Model-agnostic private chatbots and no-RAG knowledge systems are particularly suitable for sensitive regulatory content because they can be used more deterministically and are easier to document for audits. Versioning at the model and data level as well as performance monitoring (latency, cost per request, answer quality) are important.

Integration into existing products and processes

The biggest challenge is rarely the model, but the integration into existing clinical workflows and medtech product cycles. Interfaces to HIS/EMR, MES or device control must be stable and low-latency. Equally important are access controls and RBAC for different user roles in the clinic and production.

Change management starts early: training for developers, QA, regulatory-affairs teams and clinical staff is part of the technical roadmap. We recommend hybrid teams with product, AI engineering and compliance resources that deliver increments together.

Success criteria and metrics

KPIs should link technical and business outcomes: accuracy, response time, cost-per-run, number of manually corrected documents, turnaround times for approval documents, reduced defect rates in production and ultimately time-to-market for new device variants. ROI considerations must include regulatory savings and reduced audit effort.

Also important is consideration of total cost of ownership: hosting decisions, model updates, data maintenance and support effort. Self-hosted infrastructure avoids runtime costs of cloud API providers but requires more operational effort.

Common pitfalls and how to avoid them

1) Unclear scope definition: Many projects fail because PoCs are too broad. A narrow MVP scope increases the chance of success. 2) Neglected data quality: MedTech data is heterogeneous — data preparation is a central cost factor. 3) Ignored compliance paths: Late involvement of regulatory teams leads to expensive rework.

Avoidance: early involvement of QA/regulatory, iterative validation, automated tests and audit trails. We build metrics and verification paths directly into the engineering pipelines, not as an afterthought.

Timeline expectations and team requirements

A realistic schedule for a first production-near feature: PoC in 2–4 weeks, MVP within 3–6 months, production expansion and validation 6–12 months depending on regulatory requirements. Teams need data engineers, backend developers, ML engineers, DevOps/SRE and a regulatory liaison.

Our co-preneur method provides experienced engineers on short notice, complemented by local workshops in Munich and continuous handover to internal teams so that know-how remains in the company long-term.

Change management and rollout

Technology is only part of the transformation. Clinical users, production teams and regulatory departments must feel the benefit. We support change management with training, playbooks and clear rollout phases: pilot, expansion, production. Feedback loops ensure adoption and continuous improvement.

In sum: AI engineering for medical technology in Munich is a pragmatic interplay of robust models, auditable processes and infrastructural care. Those who combine these disciplines gain speed, compliance and real clinical value.

Ready for the next step?

Schedule a conversation: we will outline your first AI PoC, present architecture options and create a pragmatic roadmap for production and approval.

Key industries in Munich

Historically a center of precision manufacturing, Munich has evolved over decades into a high-tech metropolis. The combination of traditional manufacturers, insurers and a thriving startup ecosystem creates an environment in which medtech can quickly grow from research to product maturity.

The automotive industry with companies like BMW has a high demand for sensors, embedded software and reliability engineering — competencies that directly feed into the development of medical devices. Interfaces with these industries drive innovations in robustness and manufacturing efficiency.

The insurance and reinsurance sector, represented by groups like Allianz and Munich Re, influences healthcare through new financing models and data-driven prevention offerings. For medtech firms this means solutions must be not only medically sound but also economically scalable.

The technology sector, with players like Siemens or Infineon, supplies core elements for medical devices — from sensors and processors to secure communication modules. Proximity to these suppliers shortens development cycles and enables close cooperation.

Media and communications companies in Munich drive digital patient engagement models. Multidisciplinary approaches combine clinical expertise with UX design and data-driven communication — a relevant building block for patient-facing copilots and telemedicine services.

The startup scene in Munich completes the picture: young teams bring agility to product development and experiment with new business models like subscription-based services for devices. For established manufacturers this opens opportunities for cooperation or rapid integration of new software features.

For medtech companies in Munich this means: they operate in a dense ecosystem where supplier competence, insurance innovation and digital health platforms go hand in hand. AI solutions must map this network while ensuring regulatory safety.

Our work aims to make these industry intersections manageable: we focus on solutions that combine technical excellence, regulatory robustness and economic scalability — tailored to the needs of Munich-based companies.

How can we start your AI project in Munich?

We come to Munich, run workshops and deliver a PoC in days that demonstrates technical feasibility, performance and compliance requirements.

Important players in Munich

BMW is more than a carmaker; the company advances embedded systems development, sensor integration and robust software architectures. These competencies are relevant for medtech firms because similar requirements for reliability, safety and integration apply.

Siemens has a long history in medical technology and industrial automation. R&D projects at Siemens often approach the interface between medtech and infrastructure, making Munich an important node for device innovation.

Allianz and Munich Re shape the region's finance and insurance market. For manufacturers of healthcare devices, these actors are important partners regarding usage data, risk models and new business models such as outcome-based pricing.

Infineon is a global player for semiconductors whose products are increasingly used in medical devices. Proximity to semiconductor expertise simplifies the selection of components with regard to safety and longevity requirements.

Rohde & Schwarz is known for measurement and test technology. In medtech, precise measuring devices, EMC tests and test infrastructure are crucial — local providers accelerate development and certification phases.

In addition, there is a dense network of SMEs, suppliers and research institutions that collaborate closely with large players. This economy fosters cooperations where small teams rapidly develop prototypes and larger companies take over scaling.

Startups and university spin-offs complement the landscape: they push digital health offerings, work on telemedicine, image analysis and integrated patient services. The dynamic mix of tradition and agility is typical for Munich and opens up diverse partnerships.

For medtech companies this means: to be successful in Munich you must bring both technical know-how and the ability to collaborate with insurers, suppliers and clinics. We support exactly at these interfaces — with technical AI engineering and pragmatic implementation experience.

Ready for the next step?

Schedule a conversation: we will outline your first AI PoC, present architecture options and create a pragmatic roadmap for production and approval.

Frequently Asked Questions

The duration of an AI PoC depends heavily on the scope and the data situation, but we often deliver a functional prototype within a few days to a few weeks. A clear use case is decisive: which document types, what output quality and which compliance requirements are relevant? A narrowly scoped PoC — for example demonstrating the automatic generation of test protocols from existing measurement data — can produce concrete results very quickly.

In advance we need access to representative data, clear quality criteria and a list of critical stakeholders (QA, regulatory, production). We perform a quick feasibility check, choose models and architecture, and implement a minimal data pipeline to make the results reproducible.

For medtech it is additionally important that compliance aspects are considered from the start: data classification, traceability and audit trails are integrated into the architecture. This slightly extends preparation time but prevents costly rework.

Practical recommendation: schedule an initial workshop day with our engineers in Munich to clarify scope and data access. After the PoC we deliver an engineering summary and a roadmap describing the steps to validation and production.

For healthcare devices in Germany we generally recommend hosting solutions that ensure data locality, encryption and auditability. Self-hosted options (e.g., Hetzner combined with MinIO and Traefik) offer full control over data and models and reduce regulatory uncertainties because sensitive information is not transferred to third parties in third countries.

For many clients a hybrid solution makes sense: sensitive data remains on-premise or in a certified EU cloud, while less critical inference loads run in a secured cloud. In any case, it is important that all data flows are documented and technically secured, including key management and role-based access control.

Additionally, a secure architecture includes regular penetration tests, logging and monitoring as well as a clear update and incident response plan. We build these components into the infrastructure from the start so that certification audits and reviews are simpler.

Practical advice: decide early on hosting strategy together with regulatory experts and your IT. We support the proof-of-concept with self-hosted setups and show the effects on TCO and operational security.

Integrating a clinical workflow assistant requires a deep understanding of the existing interfaces (HIS/EMR, DICOM, HL7/FHIR) and clinical processes. First, we identify the relevant integration points and define API adapters to ensure data is accessible securely and in real time.

A pragmatic approach is a staged integration model: first a read-only adapter for data aggregation and UI prototyping, then gradual write or action permissions accompanied by strict verification and rollback mechanisms. This reduces risk and increases acceptance among clinical staff.

UI/UX design is also crucial: the assistant must not complicate workflows. We work closely with users, collect feedback during pilot phases and implement observation and measurement mechanisms to document effectiveness and user satisfaction.

Finally, regulatory evidence is required: validation tests, clinical evaluations and technical documentation are part of the product dossier. We support these steps with a focus on reproducible tests and audit trails so that integration and approval go hand in hand.

Private chatbots that operate without retrieval-augmented generation (no-RAG) can be very useful in regulatory contexts because they are more deterministic and easier to audit. Without dynamic retrieval from external knowledge bases, answers are more traceable, which is an advantage in audits and approval procedures.

Such chatbots can be used, for example, for internal QA guides, SOP accessibility or standardized rule tables. Responses are based on validated templates or modelled decision tables that can be versioned and signed so traceability is ensured.

Challenges include limited flexibility and the need to build controls to prevent the bot from giving inappropriate recommendations. Therefore we recommend hybrid approaches: a rule-based engine for critical statements and ML models for supportive phrasing, always with clear labeling.

Conclusion: no-RAG chatbots reduce compliance risks and can automate many regulatory routine tasks. We assist with the implementation, versioning and auditing of such solutions in medtech environments.

KPIs must link technical performance and business outcomes. On the technical side, metrics include accuracy/recall/precision (for classifiers), response latency, availability, error rates and cost-per-run. For LLMs, hallucination rate, factuality scores and stability across updates are also important measures.

On the business side, KPIs should capture time savings in documentation, reduction of manual rework, fewer audit findings, time-to-market for product variants and the number of successfully completed approval processes. For clinical assistants, patient safety metrics and user acceptance may be included.

Operational KPIs such as mean time to recovery (MTTR), deployment frequency, number of incidents and security incidents are also relevant because they demonstrate operational maturity and long-term maintainability.

It is important to define KPIs early and collect them automatically. We implement monitoring stacks that consistently capture metrics and provide dashboards for stakeholders, so decisions can be made based on data.

Organizationally, a combination of technical competence and governance is required. Companies should establish a central AI steering unit that brings together product management, engineering, regulatory and security. This unit defines roadmaps, priorities and compliance standards.

At the same time, cross-functional teams are useful: small, interdisciplinary teams with product owners, ML engineers, data engineers and regulatory liaisons accelerate development and ensure regulatory requirements are continuously considered.

Another aspect is skills development: training for developers, QA and clinical staff, workshops on data ethics and regular fire drills for incident response create operational robustness. In Munich you can often rely on local training partners and universities to build know-how quickly.

Finally, we recommend clear processes for model management, versioning and change control. Only then can updates, validations and audits be tracked cleanly. We support clients in building these organizational foundations and, if needed, take on co-pioneer roles until internal teams assume full responsibility.

Contact Us!

0/10 min.

Contact Directly

Your Contact

Philipp M. W. Hoffmann

Founder & Partner

Address

Reruption GmbH

Falkertstraße 2

70176 Stuttgart

Social Media